dc.contributor.author | Butzkueven, H. | |
dc.contributor.author | Spelman, T. | |
dc.contributor.author | Kalincik, T. | |
dc.contributor.author | Jokubaitis, V. | |
dc.contributor.author | Zhang, A. | |
dc.contributor.author | Pellegrini, F. | |
dc.contributor.author | La Spitaleri, D. | |
dc.date.accessioned | 2020-06-21T13:34:14Z | |
dc.date.available | 2020-06-21T13:34:14Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 1352-4585 | |
dc.identifier.issn | 1477-0970 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/13472 | |
dc.description | 8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS) -- NOV 19-21, 2015 -- Seoul, SOUTH KOREA | en_US |
dc.description | Belachew, Shibeshih/0000-0003-3976-1950; Horakova, Dana/0000-0003-1915-0036; Lugaresi, Alessandra/0000-0003-2902-5589; Havrdova, Eva Kubala/0000-0002-9543-4359; | en_US |
dc.description | WOS: 000372242400086 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | Pan Asian Comm Treatment & Res Multiple Sclerosis | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Sage Publications Ltd | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Efficacy and Treatment Persistence of First-line Natalizumab vs. Interferon beta or Glatiramer Acetate in relapsing MS. | en_US |
dc.type | conferenceObject | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 22 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 418 | en_US |
dc.identifier.endpage | 419 | en_US |
dc.relation.journal | Multiple Sclerosis Journal | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |